Indaptus Therapeutics, Inc. Announces Sale of $2.3 Million in Private Placement of Convertible Notes and Warrants

Stock Information for ICC International Cannabis Corp (New)

Loading

Please wait while we load your information from QuoteMedia.

More Recent News About ICC International Cannabis Corp (New)

Indaptus Therapeutics Provides Clinical Update
Indaptus Therapeutics to Present at the H.C. Wainwright 27?? Annual Global Investment Conference
Indaptus Therapeutics Reports Second Quarter 2025 Financial Results and Provides Corporate Update
Indaptus Therapeutics, Inc. Announces Additional Sale of $3.4 Million in Private Placement of Convertible Notes and Warrants
Indaptus Therapeutics Announces Reverse Stock Split
Indaptus Therapeutics Doses First Patient in Phase 1b/2 Combination Study of Decoy20 with PD-1 Checkpoint Inhibitor Tislelizumab
Indaptus Therapeutics Reports First Quarter 2025 Financial Results and Provides Corporate Update
Indaptus Therapeutics Founder and Chief Scientific Officer Dr. Michael Newman Named Chair and Expert Speaker at 6th Annual Cytokine-Based Drug Development Summit

Market data content copyright © QuoteMedia. Data delayed at least 15 minutes unless otherwise indicated (view Delay Times for all exchanges). Filings and Fundamentals by Morningstar. Insiders by Morningstar (USA) and SEDI (CDN). Analyst ratings by Zacks. Terms of Use.